FDA Approves STS101 Nasal Powder as New Treatment for Acute Migraine Satsuma’s STS101 nasal powder becomes the first and only DHE nasal powder for the acute treatment of migraine with or without aura in adults.

New #Migraine drug approved! #DHENasalPowder #FDA #MigraineDisease #RescueMeds #STS101 #Dihydroergotamine #NasalApplication #DisabilitySky #ChronicMigraine #InvisibleIllness #Neurology

www.neurologylive.com/view/fda-app...